Agreement in cognitive and clinical assessments in alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 4, 2009, Pages 344-352

  Tractenberg, Rochelle E ^a,b   Aisen, Paul S ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Outcomes assessment methods

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDNISONE; PSYCHOMOTOR PERFORMANCE;

EID: 62049084867     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209212     Document Type: Article

References (32)

1. Tractenberg RE, Weiner MF, Cummings JL, Thal LJ: Independence of changes in behavior from changes in cognition and function in persons with Alzheimer's disease: a factor-analytic approach. J Neuropsychiatry Clin Neurosci 2005;17:51-60.
2. Meulen EF, Schmand B, van Campen JP, de Koning SJ, Ponds RW, Scheltens P, Verhey FR: The seven minute screen: a neurocogni-tive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psy-chiatr y 2004;75:700-705.
3. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 14 0:566-572.
4. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
5. Mohs RC, Rosen WG, Davis KL: The Alzheimer's Disease Assessment Scale (ADAS): an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;18:448- 450.
6. Folstein M, Folstein S, McHugh P: 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
7. Leber PD: Guidelines for the Clinical Evaluation of Antidementia Drugs, First Draft. Rockville, US Food and Drug Administration, 1990.
8. Streiner DL, Norman GR: Health Measurement Scales: a Practical Guide to Their Development and Use, ed 3. London, Oxford Medical Publications, 2003.
9. Nunnally JC, Bernstein IH: Psychometric Theory, ed 3. New York, McGraw-Hill, 1994, p 120.
10. Stevens J: Applied Multivariate Statistics for the Social Sciences, ed 3. Mahwah, Lawrence Erlbaum, 1996.
11. Altman DG, Bland JM: Measurement in medicine: the analysis of method comparison studies. Statistician 1983; 32:307-317.
12. Oldham PD: Measurement in Medicine: the Interpretation of Numerical Data. London, English Universities Publishers, 1968, pp 150-151, 198-202.
13. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1: 307-310.
14. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatr y 1984;141:135 6 -1364.
15. Thal LJ: Development of the Alzheimer's Disease Cooperative Study. Int J Geriatr Psychopharmacol 1997;1:6-9.
16. Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ: A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 2000;54:588- 593.
17. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34: 939-944.
18. Aisen PS, Schafer KA, Grundman M, Pfeif-fer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study: Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003;289:2819-2826.
19. Tractenberg RE, Aisen PS, Weiner MF, Cum-mings JL, Hancock GR: Independent contributions of neural and 'higher order' deficits to symptoms in Alzheimer's disease: a latent variable modeling approach. Alzheimers Dement 2006;2:303-313.
20. Comrey AL, Lee HB: A First Course in Factor Analysis, ed 3. Hillsdale, Lawrence Erlbaum, 1992, p 243.
21. Velicer WF: Determining the number of components from the matrix of partial correlations. Psychometrika 1976;41:321-327.
22. O'Connor BP: SPSS and SAS programs for determining the number of components using parallel analysis and Velicer's MAP test. Behav Res Methods Instrum Comput 2000; 32:396-402.
23. Larsen RJ, Marx ML: An Introduction to Mathematical Statistics and Its Applications, ed 2. Englewood Cliffs, Prentice Hall, 1986.
24. Loehlin JC: Latent Variable Models: An Introduction to Factor, Path, and Structural Equation Analysis, ed 4. Mahwah, Lawrence Erlbaum, 2004.
25. Sheskin DJ: Handbook of Parametric and Nonparametric Statistical Procedures, ed 3. Boca Raton, Chapman & Hall/CRC, 2004.
26. Spearman C: The Abilities of Man: Their Nature and Measurement. New York, Macmillan, 1927 (reprinted: New York, AMS Publishers, 1981).
27. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C: The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsycholog y 2008;22:531-544.
28. Crane PK, Narasimhalu K, Gibbons LE, Mungas DM, Haneuse S, Larson EB, Kuller L, Hall K, van Belle G: Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol 2008;61:1018-1027.
29. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160.
30. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A: The consortium to establish a registry for Alzheimer's disease (CERAD). 4. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.
31. Mungas D, Reed BR: Application of item response theory for development of a global functioning measure of dementia with linear measurement properties. Stat Med 2000;19: 1631-1644.
32. Crane PK, Narasimhalu K, Gibbons LE, Mungas DM, Haneuse S, Larson EB, Kuller L, Hall K, van Belle G: Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol 2008;61:1018-1027.